UA91698C2 - Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level - Google Patents

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level

Info

Publication number
UA91698C2
UA91698C2 UAA200709149A UAA200709149A UA91698C2 UA 91698 C2 UA91698 C2 UA 91698C2 UA A200709149 A UAA200709149 A UA A200709149A UA A200709149 A UAA200709149 A UA A200709149A UA 91698 C2 UA91698 C2 UA 91698C2
Authority
UA
Ukraine
Prior art keywords
treatment
level
conditions
increasing
blood glp
Prior art date
Application number
UAA200709149A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Чжи-Лян Чу
Джеймс Н. Леонард
Хуссейн А. Аль-Шамма
Роберт М. Джоунз
Original Assignee
Арена Фармасьютікалз, Інк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Арена Фармасьютікалз, Інк. filed Critical Арена Фармасьютікалз, Інк.
Priority claimed from PCT/US2006/000510 external-priority patent/WO2006076231A2/en
Publication of UA91698C2 publication Critical patent/UA91698C2/en

Links

Abstract

The present invention concerns combination of an amount of a GPR119 agonist with an amount of a dipeptidyl peptidase IV (DPP-IV) inhibitor such that the combination provides an effect in lowering a blood glucose level or in increasing a blood GLP-1 level in a subject over that provided by the amount of the GPR119 agonist or the amount of the DPP-IV inhibitor alone and the use of such a combination for treating or preventing diabetes and conditions related thereto or conditions ameliorated by increasing a blood GLP-1 level.
UAA200709149A 2005-01-10 2006-01-09 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level UA91698C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64308605P 2005-01-10 2005-01-10
PCT/US2006/000510 WO2006076231A2 (en) 2005-01-10 2006-01-09 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level

Publications (1)

Publication Number Publication Date
UA91698C2 true UA91698C2 (en) 2010-08-25

Family

ID=39095985

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200709149A UA91698C2 (en) 2005-01-10 2006-01-09 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level

Country Status (3)

Country Link
CN (2) CN101332303B (en)
UA (1) UA91698C2 (en)
ZA (1) ZA200705470B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021235294A1 (en) * 2020-03-11 2022-09-08 Dong-A St Co., Ltd. Pharmaceutical composition for prevention or treatment of diabetes and metabolic diseases associated therewith
CN111840285A (en) * 2020-06-10 2020-10-30 苏州安康盟医疗科技有限公司 GPR17 and/or CSFR1 receptor inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1741447E (en) * 2000-01-21 2013-12-11 Novartis Ag Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents

Also Published As

Publication number Publication date
ZA200705470B (en) 2008-07-30
CN101332303A (en) 2008-12-31
CN101332303B (en) 2012-09-26
CN101128192A (en) 2008-02-20

Similar Documents

Publication Publication Date Title
SG158876A1 (en) Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
EP1761532A4 (en) Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
WO2010029089A3 (en) Combination therapy for the treatment of diabetes and related conditions
EP1756074A4 (en) 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
PT1928499E (en) Use of a dpp-iv inhibitor to reduce hypoglycemic events
WO2006000567A3 (en) Use of glp-1 receptor agonists and / or dpp-iv inhibitors in combination with proton pump inhibitors and ppar agonists for the preparation of a medicament for the treatment of diabetes type i i and impaired pancreatic beta-cell function
MX2008013135A (en) Use of gpr119 receptor agonists for increasing bone mass and for treating osteoporosis, and combination therapy relating thereto.
EP1986652A4 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
EP1978804A4 (en) Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
EP2019677A4 (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
GEP20135838B (en) Dipeptidyl peptidase inhibitors usage at diabetes treatment
MX2008013304A (en) Glp-1 compounds.
WO2007120936A3 (en) Use.of vildagliptin for the treatment of diabetes
TW200740804A (en) Glucokinase activators
TN2011000413A1 (en) Sglt-2inhibitor for treating type 1 diabetes mellitus, type 2 diabetes mellitus impaired glucose tolerance or hyperglycemia
IL190133A0 (en) Dipeptidyl peptidase inhibitors for treating diabetes
ZA200807488B (en) Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes
WO2007027225A3 (en) Combination therapy for the treatment of obesity and diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
UA91698C2 (en) Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
TW200738245A (en) Pharmaceutical composition containing FBPase inhibitor
AU2011213703B2 (en) Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level
ZA200802855B (en) Dipeptidyl peptidase inhibitors for treating diabetes